<SEC-DOCUMENT>0001213900-24-070284-index.html : 20240816
<SEC-HEADER>0001213900-24-070284.hdr.sgml : 20240816
<ACCEPTANCE-DATETIME>20240816163429
ACCESSION NUMBER:		0001213900-24-070284
CONFORMED SUBMISSION TYPE:	SC 13D
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20240816
DATE AS OF CHANGE:		20240816

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIUS ONCOLOGY, INC.
		CENTRAL INDEX KEY:			0001851484
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-93794
		FILM NUMBER:		241217172

	BUSINESS ADDRESS:	
		STREET 1:		420 LEXINGTON AVE,
		STREET 2:		SUITE 2446
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		(347) 627-0058

	MAIL ADDRESS:	
		STREET 1:		420 LEXINGTON AVE,
		STREET 2:		SUITE 2446
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TenX Keane Acquisition
		DATE OF NAME CHANGE:	20210315

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citius Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001506251
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				273425913
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		SC 13D

	BUSINESS ADDRESS:	
		STREET 1:		11 COMMERCE DRIVE
		STREET 2:		1ST FLOOR
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016
		BUSINESS PHONE:		(908) 967-6676

	MAIL ADDRESS:	
		STREET 1:		11 COMMERCE DRIVE
		STREET 2:		1ST FLOOR
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Trail One, Inc.
		DATE OF NAME CHANGE:	20110314

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TrailOne, Inc.
		DATE OF NAME CHANGE:	20101119
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D
<SEQUENCE>1
<FILENAME>ea0211485-13dciti_citiuson.htm
<DESCRIPTION>SCHEDULE 13D
<TEXT>
Document 1 - file: ea0211485-13dciti_citiuson.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea021148501ex99-1_citius.htm
<DESCRIPTION>AGREEMENT AND PLAN OF MERGER AND REORGANIZATION, DATED AS OF OCTOBER 23, 2023, BY AND AMONG CITIUS PHARMACEUTICALS, INC., CITIUS ONCOLOGY, INC., TENX KEANE ACQUISITION AND TENX MERGER SUB, INC
<TEXT>
Document 2 - file: ea021148501ex99-1_citius.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>ea021148501ex99-2_citius.htm
<DESCRIPTION>SIDE LETTER AGREEMENT, DATED AS OF AUGUST 12, 2024, BY AND BY AND AMONG CITIUS PHARMACEUTICALS, INC., CITIUS ONCOLOGY, INC., TENX KEANE ACQUISITION AND TENX MERGER SUB, INC
<TEXT>
Document 3 - file: ea021148501ex99-2_citius.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>ea021148501ex99-3_citius.htm
<DESCRIPTION>AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT, DATED AS OF AUGUST 12, 2024, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND THE SIGNATORIES THERETO
<TEXT>
Document 4 - file: ea021148501ex99-3_citius.htm

</DOCUMENT>
</SEC-DOCUMENT>